Loss of chromosome 11q21–23.1 and 17p and gain of chromosome 6p are independent prognostic indicators in B-cell non-Hodgkin’s lymphoma (original) (raw)
References
Autio K, Aalto Y, Franssila K, Elonen E, Joensuu H and Knuutila S (1998) Low number of DNA copy number changes in small lymphocytic lymphoma. Haematologica83: 690–692 CASPubMed Google Scholar
Beà S, Ribas M, Hernandez JM, Bosch F, Pinyol M, Hernandez L, Garcia JL, Flores T, Gonzalez M, Lopez-Guillermo A, Piris MA, Cardesa A, Montserrat E, Miro R and Campo E (1999) Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants. Blood93: 4365–4374 PubMed Google Scholar
Bentz M, Huck K, Manoir S, Joos S, Werner CA, Fischer K, Döhner H and Lichter P (1995) Comparative genomic hybridization in chronic B-cell leukemias shows a high incidence of chromosomal gains and losses. Blood85: 3610–3618 CASPubMed Google Scholar
Bentz M, Werner CA, Döhner H, Joos S, Barth TFE, Siebert R, Schroder M, Stilgenbauer S, Fischer K, Moller P and Lichter P (1996) High incidence of chromosomal imbalances and gene amplifications in the classical follicular variant of follicle center lymphoma. Blood88: 1437–1444 CASPubMed Google Scholar
Bentz M, Plesch A, Bullinger L, Stilgenbauer S, Ott G, Muller-Hermelink HK, Baudis M, Barth TF, Moller P, Lichter P and Döhner H (2000) t(11;14)-positive mantle cell lymphomas exhibit complex karyotypes and share similarities with B-cell chronic lymphocytic leukemia. Genes Chromosomes Cancer27: 285–294 ArticleCAS Google Scholar
Bullrich F, Rasio D, Kitada S, Starostik P, Kipps T, Keating M, Albitar M, Reed JC and Croce CM (1999) ATM mutations in B-cell chronic lymphocytic leukemia. Cancer Res59: 24–27 CASPubMed Google Scholar
Carbone PP, Kaplan HS, Musshoff K, Smithers DW and Tubiana H (1971) Report of the Committee of Hodgkin’s disease staging classification. Cancer Res31: 1860–1861 CAS Google Scholar
DeAngelis P, Clausen OPF, Schjølberg A and Stokke T (1999) Chromosomal gains and losses in primary colorectal carcinomas detected by CGH and their associations with tumour DNA ploidy, genotypes and phenotypes. Br J Cancer80: 526–535 ArticleCAS Google Scholar
Dierlamm J, Rosenberg C, Stul M, Pittaluga S, Wlodarska I, Michaux L, Dehaen M, Verhoef G, Thomas J, de Kelver W, Bakker-Schut T, Cassiman JJ, Raap AK, De Wolf-Peeters C, Van den Berghe H and Hagemeijer A (1997) Characteristic pattern of chromosomal gains and losses in marginal zone B cell lymphoma detected by comparative genomic hybridization. Leukemia11: 747–758 ArticleCAS Google Scholar
Dohner H, Fischer K, Bentz M, Hansen K, Benner A, Cabot G, Diehl D, Schlenk R, Coy J and Stilgenbauer S (1995) p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias. Blood85: 1580–1589 CASPubMed Google Scholar
Dohner H, Stilgenbauer S, James MR, Benner A, Weilguni T, Bentz M, Fischer K, Hunstein W and Lichter P (1997) 11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis. Blood89: 2516–2522 CASPubMed Google Scholar
Dohner H, Stilgenbauer S, Benner A, Leupolt E, Krober A, Bullinger L, Dohner K, Bentz M and Lichter P (2000) Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med343: 1910–1916 ArticleCAS Google Scholar
Fisher RI, Gaynor ER, Dahlberg S, Oken MM, Grogan TM, Mize EM, Glick JH, Coltman CA and Miller TP (1993) Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin’s lymphoma. N Engl J Med328: 1002–1006 ArticleCAS Google Scholar
Galteland E, Holte H and Stokke T (1999) c-MYC, RB-1, and TP53 copy number in B-cell Non-Hodgkin’s Lymphoma assessed by dual-color fluorescence in situ hybridization. Cytometry38: 53–60 ArticleCAS Google Scholar
Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, Delsol G, De Wolf Peeters C, Falini B and Gatter KC (1994) A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood84: 1361–1392 CAS Google Scholar
Heim S and Mitelman F (1995). Cancer cytogenetics, Second Edn. pp. 237–309, Wiley-Liss: New York Google Scholar
Hernandez L, Fest T, Cazorla M, Teruya-Feldstein J, Bosch F, Peinado MA, Piris MA, Montserrat E, Cardesa A, Jaffe ES, Campo E and Raffold M (1996) p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas. Blood87: 3351–3359 CASPubMed Google Scholar
Kallioniemi O-P, Kallioniemi A, Piper J, Isola J, Waldman FM, Gray JW and Pinkel D (1994a) Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer10: 231–243 ArticleCAS Google Scholar
Kallioniemi A, Kallioniemi O-P, Piper J, Tanner M, Stokke T, Chen L, Smith HS, Pinkel D, Gray JW and Waldman FM (1994b) Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. PNAS91: 2156–2160 ArticleCAS Google Scholar
Knutsen T (1998) Cytogenetic changes in the progression of lymphoma. Leuk Lymphoma31: 1–19 ArticleCAS Google Scholar
Levine AJ (1997) p53, the cellular gatekeeper for growth and division. Cell88: 323–331 ArticleCAS Google Scholar
Mitelman F, Kaneko Y and Berger R (1994) Report of the committee on chromosome changes in neoplasia. In: Human gene mapping 1993, Cuticchia AJ and Pearson PL (eds) pp. 773 John Hopkins: Baltimore, MD Google Scholar
Mitelman F, Mertens F and Johansson B (1997) A breakpoint map of recurrent chromosomal rearrangements ain human neoplasia. Nature Genetics special issue, 417–474 ArticleCAS Google Scholar
Monni O, Joensuu H, Franssila K and Knuutila S (1996) DNA copy number changes in diffuse large B-cell lymphoma-comparative genomic hybridization study. Blood87: 5269–5278 CASPubMed Google Scholar
Monni O, Joensuu H, Franssila K, Klefstrom J, Alitalo K and Knuutila S (1997) Bcl-2 overexpression associated with chromosomal amplification in diffuse large B-cell lymphoma. Blood90: 1168–1174 CASPubMed Google Scholar
Monni O, Oinonen R, Elonen E, Franssila K, Teerenhovi L, Joensuu H and Knuutila S (1998) Gain of 3q and deletion of 11q22 are frequent aberrations in mantle cell lymphoma. Genes Chromosomes Cancer21: 298–307 ArticleCAS Google Scholar
Offit K (1992) Chromosome analysis in the management of patients with Non-Hodgkin’s lymphoma. Leukemia Lymphoma7: 275–282 ArticleCAS Google Scholar
Ong ST and Le Beau MM (1998) Chromosomal abnormalities and molecular genetics of Non-Hodgkin’s lymphoma. Semin Oncol25: 447–460 CASPubMed Google Scholar
Panayiotidis P and Kotsi P (1999) Genetics of small lymphocyte disorders. Semin Hematol36: 171–177 CASPubMed Google Scholar
Pui CH and Evans WE (1998) Acute lymphoblastic leukemia. N Engl J Med339: 605–615 ArticleCAS Google Scholar
Rabbitts TH (1994) Chromosomal translocations in human cancer. Nature372: 143–149 ArticleCAS Google Scholar
Sander CA, Yano T, Clark HM, Harris C, Longo DL, Jaffe ES and Raffeld M (1993) p53 mutation is associated with progression in follicular lymphomas. Blood82: 1994–2004 CASPubMed Google Scholar
Schaffner C, Idler I, Stilgenbauer S, Döhner H and Lichter P (2000) Mantle cell lymphoma is characterized by inactivation of the ATM gene. PNAS97: 2773–2778 ArticleCAS Google Scholar
Schoch C, Rieder H, Stollmann-Gibbels B, Freund M, Tischler HJ, Silling-Engelhardt G and Fonatsch C (1995) 17p anomalies in lymphoid malignancies: diagnostic and prognostic implications. Leuk Lymphoma17: 271–279 ArticleCAS Google Scholar
Schouten HC, Sanger WG, Weisenburger DD, Anderson J and Armitage JO (1990) Chromosomal abnormalities in untreated patients with non-Hodgkin’s lymphoma: associations with histology, clinical characteristics, and treatment outcome. Blood75: 1841–1847 CASPubMed Google Scholar
Stokke T, Holte H, Smedshammer L, Smeland EB, Kaalhus O and Steen HB (1998a) Proliferation and apoptosis in malignant and normal cells in B-cell Non-Hodgkins lymphomas. Br J Cancer77: 1832–1838 ArticleCAS Google Scholar
Stokke T, Smeland EB, Kvaløy S and Holte H (1998b) Tumor cell proliferation, but not apoptosis, predicts survival in B-cell Non-Hodgkins lymphomas. Br J Cancer77: 1839–1841 ArticleCAS Google Scholar
Stokke T, Galteland E, Holte H, Smedshammer L, Suo Z, Smeland EB, Børresen-Dale A-L, DeAngelis P and Steen HB (2000) Oncogenic aberrations in the p53 pathway are associated with a high S phase fraction and poor survival in B cell Non-Hodgkin’s lymphoma. Int J Cancer89: 313–324 ArticleCAS Google Scholar
The International Non-Hodgkin’s Lymphoma Prognostic Factors Project (1993) A predictive model for aggressive non-Hodgkin’s lymphoma. N Engl J Med329: 987–994
Tilly H, Rossi A, Stamatoullas A, Lenormand B, Bigorgne C, Kunlin A, Monconduit and Bastard C (1994) Prognostic value of chromosomal abnormalities in follicular lymphoma. Blood84: 1043–1049 CASPubMed Google Scholar
Tirkkonen M, Tanner M, Karhu R, Kallioniemi A, Isola J and Kallioniemi O-P (1998) Molecular cytogenetics of primary breast cancer by CGH. Genes Chromosom Cancer21: 177–184 ArticleCAS Google Scholar